Suma Krishnan

President, R&D

Suma Krishnan (President, R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $10.9M of KRYS (49,456 sh across 14 lots, as filed), executed Dec 4 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$33.9M

shares × price, as filed

Last traded

Sep 4

Filed Sep 4

Median ADV $140.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $58.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

KRYS

Krystal Biotech, Inc. KRYS · 0 buys · 8 sells 8 filings

Recent filings

KRYSSALE Krystal Biotech, Inc. View filing → $9.0M
25,000 sh across 13 lots
Exec Sep 4
Filed Sep 4 · 7:15 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $7.5M
24,193 sh across 8 lots
Exec Jun 4
Filed Jun 5 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $6.6M
25,000 sh across 10 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $10.9M
49,456 sh across 14 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $5.4M
35,773 sh across 8 lots
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $2.0M
13,127 sh across 2 lots
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $8.9M
50,000 sh across 10 lots
Exec Mar 13 2025
Filed Mar 13 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $8.2M
49,800 sh across 16 lots
Exec Dec 13 2024
Filed Dec 13 2024 · 5:30 PM ET More filings →